Biologic Options in Pediatric Asthma

The panel discusses the biologic drugs approved for use in children with asthma, including omalizumab, dupilumab, mepolizumab, and the recently approved benralizumab. They share their preferences among these options for improving lung function in pediatric patients.

Related Content:

Allergies, Asthma Exacerbations and Uncontrolled Asthma ManagementAsthmaPeer Exchange

First Fungal Spore Calendar Developed for Patients with Asthma, Allergies

Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson

Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma